Alliance Pharma (GB:APH) has released an update.
Slater Investments has increased its stake in Alliance Pharma PLC, crossing the notification threshold with a new total of 12% voting rights as of January 4, 2024. This significant acquisition comprises both direct and indirect voting rights, amounting to 64,825,000 voting rights within the healthcare company. The notification was completed on January 5, 2024, in London.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
